Zobrazeno 1 - 10
of 58
pro vyhledávání: '"I A, Pokataev"'
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 4, Pp 34-43 (2023)
The objective of the study is to compare the effectiveness of various systemic therapies in the 3rd and subsequent lines of therapy of metastatic colon cancer. Material and Methods. Retrospective multicenter study collected data from 2 clinics of the
Externí odkaz:
https://doaj.org/article/b9138cfdefc0410db5d7db392cc8f087
Autor:
A. N. Polyakov, D. A. Granov, Yu. I. Patyutko, I. A. Pokataev, A. A. Polikarpov, T. I. Kagacheva, I. S. Bazin, A. Sh. Umirzokov, D. Yu. Frantsev, V. N. Zhuikov, D. V. Podluzhny
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 1, Pp 57-67 (2023)
Purpose of the study was to evaluate the safety and feasibility of preoperative chemotherapy in intrahepatic cholangiocarcinoma (IHCC).Patients and methods. A total of 171 liver resections for IHCC were performed between 2007 and 2021, of which 24 we
Externí odkaz:
https://doaj.org/article/8b7912970b194880888362c58fb7b006
Autor:
A. A. Rumyantsev, A. S. Tyulyandina, I. A. Pokataev, E. R. Israelyan, M. Е. Abramov, H. N. Lud, S. A. Tyulyandin
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 77-83 (2022)
Introduction. Olaparib is the only PARP inhibitor approved in Russia for the maintenance therapy for BRCA-positive ovarian cancer after frontline chemotherapy. We conducted a real-world analysis of olaparib efficacy and safety for this indication.Aim
Externí odkaz:
https://doaj.org/article/bfaddd974a224ac8b80f777641cf367f
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 1, Pp 87-96 (2022)
Endometrial cancer is the most common gynecologic malignancy in Russia. Surgery and/or chemoand radiotherapy remain standard clinical approach. This review describes multidisciplinary approach as the state of the art in the disease management. We not
Externí odkaz:
https://doaj.org/article/b0fe3cf8dde748e583ff8991edca6588
Autor:
M. A. Lyadova, V. K. Lyadov, O. A. Pardabekova, I. A. Pokataev, M. E. Ivannikov, Ya. V. Koroleva, E. S. Chernysheva, K. V. Lyadov
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 18-23 (2021)
Introduction. The discovery of immune checkpoints and immune checkpoint inhibitors (ICI) became a breakthrough in medical oncology. Currently a search for most effective and safe schemes of ICI therapy for different cancers is ongoing.Aim. To evaluat
Externí odkaz:
https://doaj.org/article/5feb869ecb58418698cd2a42b26125a4
Autor:
M. Yu. Fedyanin, E. M. Polyanskaya, H. H.-M. Elsnukaeva, A. A. Tryakin, I. A. Pokataev, A. A. Bulanov, S. A. Tjulandin
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 125-132 (2020)
Introduction. Based on the subgroup analysis of the TRIBE study FOLFOXIRI with bevacizumab is the recommended option for patients (pts) with mBRAF metastatic colorectal cancer (mCRC) in the 1st line. However, subgroup analysis of other studies showed
Externí odkaz:
https://doaj.org/article/ee57e07abaa94e0ca701173d11ac940a
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 127-132 (2020)
The method of liquid biopsy allows detection of circulating tumor DNA (ctDNA) in patient blood, but the clinical significance of this approach in pancreatic cancer is still unclear. In this regard, we have carried out a meta-analysis of the studies d
Externí odkaz:
https://doaj.org/article/f2f63872666442ca9b88808706982b06
Autor:
E. O. Ignatova, D. A. Seryak, M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. F. Menshikova, Yu. V. Vakhabova, M. S. Karbyshev, K. V. Smirnova, S. A. Tulyandin
Publikováno v:
Успехи молекулярной онкологии, Vol 7, Iss 3, Pp 27-36 (2020)
Epstein–Barr virus (EBV) associated gastric carcinoma is a special form of gastric adenocarcinoma that arises against the background of clonal growth of EBV-infected epithelial cells of the gastric mucosa. This subtype of tumors has unique genetic
Externí odkaz:
https://doaj.org/article/14eaec726b784aa39fac2abcc0fb1713
Autor:
E. Yu. Antonova, I. S. Bazin, A. M. Garin, I. A. Pokataev, I. B. Sagaidak, A. N. Polyakov, Y. E. Chihareva, A. Yu. Volkov, I. V. Bazina
Publikováno v:
Сибирский онкологический журнал, Vol 19, Iss 3, Pp 156-163 (2020)
Purpose of the study was to provide medical oncologists and surgeons specializing in the treatment of pancreatic cancer patients with the most recent information on the importance and role of chemotherapy in the treatment of patients with resectable
Externí odkaz:
https://doaj.org/article/d9b727173772462eb344feba139c3f0c
Autor:
I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 74-82 (2019)
Introduction. The randomized MPACT study showed that nab-paclitaxel plus gemcitabine results in statistically significantly longer life expectancy. The objective of this retrospective study is to obtain relevant data on the efficacy of this combinati
Externí odkaz:
https://doaj.org/article/edea90a163bc42438bb0f9e0ef411a7b